Maharukh Rustomjee – Founder and Managing Partner of Amaterasu, is a leading scientific figure in research and development, pharmaceutical product innovation, product formulation, manufacturing innovation and regulatory sciences. She has an enviable track record of innovations across Formulations and Drug Delivery Systems. In a career spanning 35 years, she has worked with leading organisations like Novartis, Ciba-Geigy, GSK and Burroughs Welcome, going on become an entrepreneur in 1999. She co-founded Rubicon Research – India’s pioneering contract research and drug delivery company. At Rubicon she was leading R&D and operations. She exited Rubicon in the year 2016 and set up Amaterasu in the same year.

She is published widely, authored a book and holds numerous patents. She has spearheaded several drug delivery technology projects, built a strong intellectual property knowledge base, developed strong generics and commercialised patent regime benefits through FTF (First to File) and LCM (Life Cycle Management) opportunities. She has won several awards individually and for the organisations she has been associated with and is a leading voice in the Indian and international healthcare and pharmaceutical community.